-
Laboratory changes of the liver function in the patients with Wilson’s disease
-
Lance – Adams Syndrome: a Case Series from Vietnam
-
Late-onset neurologic Wilson’s disease: case series
-
Latent Genetic Architecture of Parkinson’s Disease Risk factors and Comorbidities
-
Leg Stereotypy Syndrome: Phenomenological and Quantitative Analysis
-
Legmain/Asparaginyl endopeptidase-resistant tau fibril fold produces corticobasal degeneration-specific C-terminal tau fragment
-
Lessons from the COVID-19 Lockdown: A Novel Mentorship Program for Young Neurosurgeons, Neurologists and Medical Students
-
Levels of change in interleukin-6 levels according to clinical forms of Parkinson’s disease in patients with and without Covid-19
-
Levels of change in interleukin-6 levels according to clinical stages of Parkinson’s disease in patients with and without Covid-19
-
Levels of ferritinemia in Parkinson’s disease patients who underwent Covid-19
-
Leveraging Large-Scale Proteomics to Identify Protein Quantitative Trait Loci and Causal Effects on Parkinson’s Disease
-
Levodopa response is an inadequate and often biased correlate of STN-DBS outcomes
-
Levodopa-Entacapone-Carbidopa Intestinal Gel in the treatment of advanced Parkinson’s disease: a two-year experience
-
Levodopa-Entacapone-Carbidopa Intestinal Gel Treatment In Parkinson’s Disease: A Single-Center Retrospective Chart Study
-
Lifestyle Medicine for Cervical Dystonia: a New View on Treatment
-
Linear Mixed-Effect Modelling of Antisaccades in Parkinson’s Disease and Progressive Supranuclear Palsy
-
Lingual-Masticatory Myorhythmia and Palatal Tremor as a Presentation of Anti-IgLON5 Disease
-
Listening to the Insight: The Underdiagnosis of Depression in People Living with Parkinson’s Disease
-
Lithium Therapy Associated with Reductions in Serum Neurofilament Light Chain (NfL) in Parkinson’s Disease.
-
Loganic Acid Alleviates the Bidirectional Olfactory-Brain NLRP3 Inflammasome Activation and Rescues Dopaminergic Neurons in Experimental Models of Parkinson’s Disease
-
Loneliness Relates to Gait Over Other Features of Parkinsonism
-
Long term evaluation of gluten-free diet in Parkinson´s disease patients
-
Long-read sequencing to identify unrevealed second hit in autosomal recessive Parkinson’s disease
-
Long-term Blood Pressure Measures in Incident Parkinson’s Disease in the Framingham Heart Study.
-
Long-term effects of Deep Brain Stimulation on gait and postural control in Parkinson’s disease
-
Long-Term Efficacy of 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612) for Motor Fluctuations in Parkinson’s Disease
-
Long-term evaluation of advanced Parkinson’s disease burden and clinical outcomes: results from the PROSPECT observational study
-
Long-Term Evolution of Advanced Parkinson’s Disease Burden: Subgroup Analysis from the 24 Month International PROSPECT Observational Study
-
Long-term follow up of unilateral deep brain stimulation for Parkinson’s disease
-
Long-term Physical Exercise on Bone Mineral Density, Balance and Gait in Older Adults with Mild to Moderate Parkinson’s Disease
-
Long-term Safety and Efficacy for Motor Fluctuations and Quality of Life With Foslevodopa/Foscarbidopa in Patients With Advanced Parkinson’s Disease: Interim Results From an Ongoing Open Label Extension
-
Long-Term Safety and Efficacy of Foscarbidopa/Foslevodopa in Patients with Advanced Parkinson’s Disease: Results From an Ongoing Phase 3 Open-Label Extension with Up to 1 Year Follow-Up
-
Long-term Safety of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension
-
Longevity of Motor Benefit Achieved with Deep Brain Stimulation (DBS) of the Subthalamic Nucleus (STN) in a Single Center Cohort at the Decade Mark Post-Implantation.
-
Longitudinal Analysis of fragile X-associated tremor/ataxia syndrome Progression: A One-Year Follow-Up of 24 Patients
-
Longitudinal Assessment of Dystonic Symptoms in Rapid-Onset Dystonia-Parkinsonism: genetic dystonia symptoms vary over time
-
Longitudinal change in brain function and structure related to plasma neurofilament light protein in early-stage Parkinson’s disease
-
Longitudinal Changes in Quality of Life After Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease
-
Longitudinal Gait Speed Analysis at Prodromal and Early Stage of Parkinson’s Disease
-
Longitudinal patterns of Anxiety and Depression in patients with Parkinson’s Disease
-
Longitudinal progress and clinical relevance of 18F-Florzolutau PET in patients with PSP: a one-year follow-up study
-
Longitudinal Relationship Between Brain Metabolism and Clinical Changes in Huntington’s Disease
-
Longitudinal Structural and Functional Correlates of Progression in Isolated Rapid Eye Movement Sleep Behaviour Disorder
-
Longitudinal Studies of LFP Activities During Acute and Chronic DBS Stimulation in PD Patients
-
Looking Away: Anxiety Interferes with the Ability of Freezers to Attend to Visual Cues
-
Low intensity focused pulsed ultrasound as a treatment of essential tremor: a case series
-
Lower Incidence of Parkinson’s Disease in Patients with Metabolic Syndrome or any of its Components: A Longitudinal Study
-
Lower plasma piperine levels in Parkinson’s disease: a PPMI metabolomics analysis
-
LRRK2 and GBA Founder Mutations and their Interactions in Parkinson’s Disease
-
LRRK2 G2019S mutant damages mitochondrial transfer by a Drp1-STX17 depend pathway in Parkinson’s disease
-
LRRK2 Gene Mutation in Parkinson’s Disease
-
LRRK2 I1371V Mutation: Unraveling Pathogenic Mechanisms in Dopaminergic Neurons via Membrane Fluidity & Calcium Dysregulation using PD Patient iPSCs
-
LRRK2 in Parkinson’s Disease: A per-domain rare-variant burden study
-
LRRK2 inhibition by BIIB122/DNL151 in participants with Pathogenic LRRK2 Variants and Parkinson’s disease: Study Design to Evaluate Safety, Pharmacodynamics and Pharmacokinetics
-
LRRK2-Associated Parkinsonism With and Without In Vivo Evidence of Pathologic Alpha-Synuclein: Clinical and Biomarker Characterization
-
Lumbar Punctures in Parkinson’s Research
-
Lyme disease presenting as a rapidly progressive MSA-C look alike
-
Lysosomal network defects in parkinsonian patients carrying rare variants in lysosomal hydrolytic enzyme genes
2024 International Congress
September 27-October 1, 2024. Philadelphia, PA.